Skip to Main Content
Contribute Try STAT+ Today

Top of the morning to you, and a fine one it is. Clear skies and cool breezes are wafting over the Pharmalot campus, where the official mascot has already had a play date and the short person is emerging from a deep slumber. As for us, we are busy tackling our usual routine of brewing cups of stimulation. Our choice today is vanilla macadamia nut, another of our latest picks for invigorating the neurons. Feel free to join us, of course. Meanwhile, here are a few items of interest to help you along. Hope you have a successful and productive day. And of course, do keep in touch. We appreciate your tips and suggestions. …

As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a median of 4.9% on more than 450 prescription medicines, an overall annual increase that is comparable to the price hikes seen over the past three years, STAT writes, citing a new analysis. The numbers are preliminary, though, since not every company has reported their latest prices to industry databases. Nonetheless, the early indication is that many drug makers are keeping price hikes in check due to ongoing bad publicity that has sparked sustained political pressure.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment